Aicardi-Goutieres syndrome-like encephalitis in mutant mice with constitutively active MDA5

MDA5 is a cytoplasmic sensor of viral RNA, triggering type I interferon (IFN-I) production. Constitutively active MDA5 has been linked to autoimmune diseases such as systemic lupus erythematosus, Singleton-Merten syndrome (SMS) and Aicardi-Goutieres syndrome (AGS), a genetically determined inflammatory encephalopathy. However, AGS research is challenging due to the lack of animal models. We previously reported lupus-like nephritis and SMS-like bone abnormalities in adult mice with constitutively active MDA5 (Ifih1(G821S/+)), and herein demonstrate that these mice also exhibit high lethality and spontaneous encephalitis with high IFN-I production during the early postnatal period. Increases in the number of microglia were observed in MDA5/MAVS signaling- and IFN-I-dependent manners. Furthermore, microglia showed an activated state with an increased phagocytic capability and reduced expression of neurotrophic factors. Although multiple auto-antibodies including lupus-related ones were detected in the sera of the mice as well as AGS patients, Ifih1(G821S/+)Rag2(-/-) mice also exhibited up-regulation of IFN-I, astrogliosis and microgliosis, indicating that auto-antibodies or lymphocytes are not required for the development of the encephalitis. The IFN-I signature without lymphocytic infiltration observed in Ifih1(G821S/+) mice is a typical feature of AGS. Collectively, our results suggest that the Ifih1(G821S/+) mice are a model recapitulating AGS and that microglia are a potential target for AGS therapy.

Automated summary

MDA5, as a cytoplasmic sensor of viral RNA triggering IFN-I production, has been linked to autoimmune diseases and AGS. Studies on mice with constitutively active MDA5 have revealed typical features of AGS, suggesting that microglia could be a potential target for AGS therapy.